WallStSmart
JAGX

Jaguar Animal Health Inc

NASDAQ: JAGX · HEALTHCARE · BIOTECHNOLOGY

$6.96
+2993.33% today

Updated 2026-04-30

Market cap
$3.65M
P/E ratio
P/S ratio
0.32x
EPS (TTM)
$-22.97
Dividend yield
52W range
$0 – $13
Volume
0.6M

Jaguar Animal Health Inc (JAGX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-168.4%
Last 4 quarters
Revenue YoY growth
-0.8%
Most recent quarter
EPS YoY growth
-498.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+6.2%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+6.2%
2025-11-14
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-11-14$-6.28-2754.5%$1.70$1.81+6.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$-0.22$-6.28-2754.5%$3.08M-0.8%
2025-06-30$-0.28$-10.26-3564.3%$2.98M+9.5%
2025-03-31$-10.82$-18.77-73.5%$2.21M-5.8%
2024-12-31$-18.50$-125.80-580.0%$3.51M
2024-09-30$-2.37$-1.05+55.7%$3.11M+10.5%
2024-06-30$-1.20$-4.04-236.7%$2.72M+1.7%
2024-03-31$-0.03$-0.07-133.3%$2.35M+19.2%
2023-12-31$-73.80$-33.00+55.3%
2023-09-30$-1.23$-0.55+55.3%$2.81M
2023-06-30$-1.53$-0.69+54.9%$2.68M
2023-03-31$-0.04$-2.39-5870.3%$1.97M
2022-12-31$-9.75$-3.43+64.8%

Frequently asked questions

Has Jaguar Animal Health Inc beaten earnings estimates?
Jaguar Animal Health Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -168.4% over the last 4 quarters.
How does JAGX stock react to earnings?
JAGX stock has moved an average of +6.2% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.
What is Jaguar Animal Health Inc's revenue growth rate?
Jaguar Animal Health Inc reported year-over-year revenue growth of -0.8% in its most recent quarter, with EPS growing -498.1% year-over-year.